Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2.
COVID-19
HMW adiponectin
SARS-CoV-2
adipose tissue
leptin
resistin
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
06 Jan 2023
06 Jan 2023
Historique:
received:
29
09
2022
revised:
28
12
2022
accepted:
02
01
2023
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
25
1
2023
Statut:
epublish
Résumé
Obesity, through adipose tissue (AT) inflammation and dysregulation, represents a critical factor for COVID-19; here, we investigated whether serum levels of adiponectin, HMW oligomers, leptin, and resistin are modulated and/or correlated with clinical and biochemical parameters of severe COVID-19 patients. This study included 62 severe COVID-19 patients; 62 age and sex-matched healthy subjects were recruited as a control group. Anthropometric and biochemical parameters were obtained and compared. Adiponectin, HMW oligomers, leptin, and resistin were analyzed by ELISA. The adiponectin oligomerization state was visualized by Western blotting. When compared to healthy subjects, total adiponectin levels were statistically lower in severe COVID-19 while, in contrast, the levels of leptin and resistin were statistically higher. Interestingly, HMW adiponectin oligomers negatively correlated with leptin and were positively associated with LUS scores. Resistin showed a positive association with IL-6, IL-2R, and KL-6. Our data strongly support that adipose tissue might play a functional role in COVID-19. Although it needs to be confirmed in larger cohorts, adiponectin HMW oligomers might represent a laboratory resource to predict patient seriousness. Whether adipokines can be integrated as a potential additional tool in the evolving landscape of biomarkers for the COVID-19 disease is still a matter of debate. Other studies are needed to understand the molecular mechanisms behind adipokine's involvement in COVID-19.
Identifiants
pubmed: 36674646
pii: ijms24021131
doi: 10.3390/ijms24021131
pmc: PMC9861572
pii:
doi:
Substances chimiques
Adiponectin
0
Leptin
0
Resistin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Pers Med. 2022 Mar 03;12(3):
pubmed: 35330391
Pulm Pharmacol Ther. 2016 Oct;40:104-8
pubmed: 27470682
Int J Prev Med. 2020 Sep 03;11:136
pubmed: 33088464
Front Endocrinol (Lausanne). 2021 Apr 15;12:576619
pubmed: 33935962
Am J Respir Cell Mol Biol. 2021 Jul;65(1):13-21
pubmed: 33797351
Biomolecules. 2020 Jun 18;10(6):
pubmed: 32570854
Int J Mol Sci. 2021 Mar 20;22(6):
pubmed: 33804765
J Cyst Fibros. 2019 Jan;18(1):64-70
pubmed: 29937317
Open Forum Infect Dis. 2021 Mar 01;8(3):ofab090
pubmed: 33796601
Surg Pract. 2021 Feb;25(1):2-3
pubmed: 33821164
Obesity (Silver Spring). 2020 Oct;28(10):1795
pubmed: 32619294
Pulm Pharmacol Ther. 2017 Apr;43:20-25
pubmed: 28115224
Biomedicines. 2021 May 27;9(6):
pubmed: 34072088
J Cardiol. 2014 Apr;63(4):250-9
pubmed: 24355497
Heliyon. 2021 May;7(5):e07112
pubmed: 34036187
Eur J Intern Med. 2021 Sep;91:3-9
pubmed: 33858724
COPD. 2021 Feb;18(1):70-75
pubmed: 33302720
Cells. 2021 Apr 17;10(4):
pubmed: 33920604
Rev Endocr Metab Disord. 2014 Jun;15(2):125-36
pubmed: 23990400
BMJ Nutr Prev Health. 2022 Jan 19;5(1):10-18
pubmed: 35814718
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Pulm Pharmacol Ther. 2019 Apr;55:25-30
pubmed: 30654148
Obes Facts. 2021;14(6):579-585
pubmed: 34569546
Heliyon. 2020 Aug;6(8):e04696
pubmed: 32844126
Life (Basel). 2022 Jul 28;12(8):
pubmed: 36013321
Int J Mol Sci. 2021 Mar 05;22(5):
pubmed: 33807959
J Leukoc Biol. 2021 Jul;110(1):9-20
pubmed: 33404078
Mol Cell Biochem. 2022 Apr;477(4):1155-1193
pubmed: 35084674
Biomed Res Int. 2014;2014:658913
pubmed: 25110685
Monaldi Arch Chest Dis. 2020 May 19;90(2):
pubmed: 32425013
J Immunol. 2012 Jan 15;188(2):854-63
pubmed: 22156343
Int J Mol Sci. 2022 May 13;23(10):
pubmed: 35628271
Int J Tuberc Lung Dis. 2021 Jan 1;25(1):31-35
pubmed: 33384042
J Inflamm (Lond). 2011 May 26;8:12
pubmed: 21615949
Front Immunol. 2022 Jun 16;13:830061
pubmed: 35784283
Front Immunol. 2021 Jun 18;12:649359
pubmed: 34220807
Clin Obes. 2022 Nov 25;:e12568
pubmed: 36426776
Physiol Rep. 2021 Apr;9(7):e14843
pubmed: 33904656
J Clin Med. 2021 Apr 07;10(8):
pubmed: 33916917
Chest. 2020 Mar;157(3):580-589
pubmed: 31678306
Crit Care Med. 2020 Jun;48(6):e440-e469
pubmed: 32224769
Transl Oncol. 2021 Oct;14(10):101178
pubmed: 34293684
Int J Endocrinol. 2020 Nov 28;2020:8896536
pubmed: 33312199